| Original language | English |
|---|---|
| Journal | European Journal of Clinical Pharmacology |
| Volume | 79 |
| Issue number | 4 |
| Pages (from-to) | 571-574 |
| Number of pages | 4 |
| ISSN | 0031-6970 |
| DOIs | |
| Publication status | Published - 04.2023 |
Funding
This work was supported by Erasmus+ , grant numbers 2019‐1 ‐ NL01 ‐ KA203‐060492, 2020–1-NL01-KA203-083098, and 2022–1-NL01-KA220-HED-000088069. Robert Likic, Unit of Clinical Pharmacology, Department of Internal Medicine, University Hospital Centre Zagreb and University of Zagreb School of Medicine, Zagreb, Croatia; Ylva Böttiger, Department of Medical and Health Sciences, Linköping University, Linköping, Sweden; Thierry Christiaens, Department of Clinical Pharmacology, Ghent University, Ghent, Belgium; Cornelis Kramers, Department of Pharmacology-Toxicology, Radboud University Medical Center, Nijmegen, The Netherlands; João N. Costa, Laboratory of Clinical Pharmacology and Therapeutics, Faculty of Medicine, University of Lisbon, Lisbon, Portugal; Emilio J Sanz, School of Health Science, Universidad de La Laguna, Tenerife, Spain And Hospital Universitario de Canarias. La Laguna. Tenerife. Spain; Paraskevi Papaioannidou, 1st Department of Pharmacology, School of Medicine, Faculty of Health Sciences, Aristotle University of Thessaloniki, Thessaloniki, Greece; Joost Piët, Department of Internal Medicine, Unit Pharmacotherapy, Amsterdam UMC, Vrije Universiteit Amsterdam, De Boelelaan 1117, 1081HV Amsterdam, The Netherlands, Research and Expertise Centre in Pharmacotherapy Education (RECIPE), Amsterdam, The Netherlands; Lorena Dima, Transilvania University of Brașov, Faculty of Medicine, Brașov, Romania; Jeroen van Smeden, Division of education, Centre for Human Drug Research, Leiden, The Netherland; Jitka Rychlícková, Department of Anesthesiology and Intensive Care, St. Anne's University Hospital Brno and Faculty of Medicine, Masaryk University; Floor van Rosse, Department of Hospital Pharmacy, Erasmus MC, University Medical Center Rotterdam, Rotterdam, The Netherlands; Susanna M. Wallerstedt, Department of Pharmacology, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden; Markus Schwaninger, Institute for Experimental and Clinical Pharmacology and Toxicology, University of Lübeck, Lübeck, Germany; Yves-Marie Pers, RMB, University of Montpellier, Inserm U1183, CHU Montpellier, Montpellier, France; David J. Brinkman, Department of Internal Medicine, Unit Pharmacotherapy, Amsterdam UMC, Vrije Universiteit Amsterdam, De Boelelaan 1117, 1081HV Amsterdam, The Netherlands, Research and Expertise Centre in Pharmacotherapy Education (RECIPE), Amsterdam, The Netherlands; Carla Sans-Pola, Department of Clinical Pharmacology, Vall d'Hebron Hospital Universitari, Barcelona, Spain; Jamie J. Coleman, University of Birmingham, Institute of Clinical Sciences, Birmingham, UK; Romaldas Maciulaitis, Lithuanian University of Health Sciences, Institute of Physiology and Pharmacology, Kaunas, Lithuania; Bogdan Ionel Tamba, Department of Pharmacology, Clinical Pharmacology and Algesiology, Grigore T. Popa University of Medicine and Pharmacy, Iasi, Romania.
UN SDGs
This output contributes to the following UN Sustainable Development Goals (SDGs)
-
SDG 3 Good Health and Well-being
Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver